Gustavo Angarita

Director, Yale Cocaine Research Clinic, Psychiatry · Yale-New Haven Hospital

Credentials: · · · · · · ·

History

Imaging Brain Kappa Opioid Receptors in Early Abstinence Opioid Use Disorder
National Institute on Drug Abuse · R01
Contact PI · $1.6M · Yale University
2025–2030
Assessing Central Muscarinic Acetylcholine Type-1 Receptors in Cocaine Use Disorder with 11C-LSN3172176.
National Institute on Drug Abuse · R33
Contact PI · $2.4M · Yale University
2022–2027
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C UCB J PET Study
National Institute on Drug Abuse · R01
Contact PI · $3.7M · Yale University
2021–2027
A 11C-UCB-J PET Study of Synaptic Density in Binge Eating Disorder (BED)
National Institute of Mental Health · R21
PI · $460.6K · Yale University
2023–2026

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
Principal investigator · Recruiting · Phase 1
Yale University
2025–2027
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
Principal investigator · Active not recruiting
Yale University
2021–2027
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
Principal investigator · Completed · Phase 1
Yale University
2014–2018
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS
Principal investigator · Completed · Phase 1
Yale University
2014–2022